Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • @dohpaz42English
    1•1 year ago

    That makes sense. I worry that with how the courts are today, that they (Big Pharma) might win and - as you said - be able to charge even more for drugs, and there’s nothing anyone can do but pay it.